On the Dual Uses of Science and Ethics Principles, Practices, and Prospects
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Public Health Ethics: Cases Spanning the Globe (Pp
King’s Research Portal DOI: 10.1007/978-3-319-23847-0 Document Version Publisher's PDF, also known as Version of record Link to publication record in King's Research Portal Citation for published version (APA): Johansson Blight, K. B. (2016). Can asylum be managed ethically? In Public Health Ethics: Cases Spanning the Globe (pp. 230-233). (Public Health Ethics Analysis; No. 3). Springer. https://doi.org/10.1007/978-3-319-23847-0 Citing this paper Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination, volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are again advised to check the publisher's website for any subsequent corrections. General rights Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights. •Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research. •You may not further distribute the material or use it for any profit-making activity or commercial gain •You may freely distribute the URL identifying the publication in the Research Portal Take down policy If you believe that this document breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. -
The Bio Revolution: Innovations Transforming and Our Societies, Economies, Lives
The Bio Revolution: Innovations transforming economies, societies, and our lives economies, societies, our and transforming Innovations Revolution: Bio The The Bio Revolution Innovations transforming economies, societies, and our lives May 2020 McKinsey Global Institute Since its founding in 1990, the McKinsey Global Institute (MGI) has sought to develop a deeper understanding of the evolving global economy. As the business and economics research arm of McKinsey & Company, MGI aims to help leaders in the commercial, public, and social sectors understand trends and forces shaping the global economy. MGI research combines the disciplines of economics and management, employing the analytical tools of economics with the insights of business leaders. Our “micro-to-macro” methodology examines microeconomic industry trends to better understand the broad macroeconomic forces affecting business strategy and public policy. MGI’s in-depth reports have covered more than 20 countries and 30 industries. Current research focuses on six themes: productivity and growth, natural resources, labor markets, the evolution of global financial markets, the economic impact of technology and innovation, and urbanization. Recent reports have assessed the digital economy, the impact of AI and automation on employment, physical climate risk, income inequal ity, the productivity puzzle, the economic benefits of tackling gender inequality, a new era of global competition, Chinese innovation, and digital and financial globalization. MGI is led by three McKinsey & Company senior partners: co-chairs James Manyika and Sven Smit, and director Jonathan Woetzel. Michael Chui, Susan Lund, Anu Madgavkar, Jan Mischke, Sree Ramaswamy, Jaana Remes, Jeongmin Seong, and Tilman Tacke are MGI partners, and Mekala Krishnan is an MGI senior fellow. -
Operational Requirements for Soldier-Robot Teaming
CAN UNCLASSIFIED Operational Requirements for Soldier-Robot Teaming Simon Banbury Kevin Heffner Hugh Liu Serge Pelletier Calian Ltd. Prepared by: Calian Ltd. 770 Palladium Drive Ottawa, Canada K2V 1C8 Contractor Document Number: DND-1144.1.1-01 PSPC Contract Number: W7719-185397/001/TOR Technical Authority: Ming Hou, DRDC – Toronto Research Centre Contractor's date of publication: August 2020 The body of this CAN UNCLASSIFIED document does not contain the required security banners according to DND security standards. However, it must be treated as CAN UNCLASSIFIED and protected appropriately based on the terms and conditions specified on the covering page. Defence Research and Development Canada Contract Report DRDC-RDDC-2020-C172 November 2020 CAN UNCLASSIFIED CAN UNCLASSIFIED IMPORTANT INFORMATIVE STATEMENTS This document was reviewed for Controlled Goods by Defence Research and Development Canada using the Schedule to the Defence Production Act. Disclaimer: This document is not published by the Editorial Office of Defence Research and Development Canada, an agency of the Department of National Defence of Canada but is to be catalogued in the Canadian Defence Information System (CANDIS), the national repository for Defence S&T documents. Her Majesty the Queen in Right of Canada (Department of National Defence) makes no representations or warranties, expressed or implied, of any kind whatsoever, and assumes no liability for the accuracy, reliability, completeness, currency or usefulness of any information, product, process or material included in this document. Nothing in this document should be interpreted as an endorsement for the specific use of any tool, technique or process examined in it. Any reliance on, or use of, any information, product, process or material included in this document is at the sole risk of the person so using it or relying on it. -
Synthetic Biology an Overview of the Debates
SYNTHETIC BIOLOGY PROJECT / SYNBIO 3 SYNTHETIC BIOLOGY Ethical Issuesin SYNBIO 3/JUNE2009 An overview ofthedebates Contents Preface 3 Executive Summary 4 Who is doing what, where are they doing it and how is this current work funded? 6 How distinct is synthetic biology from other emerging areas of scientific and technological innovation? 9 Ethics: What harms and benefits are associated with synthetic biology? 12 The pro-actionary and pre-cautionary frameworks 18 N OVERVIEW OF THE DEBATES N OVERVIEW OF A Competing—and potentially complementary—views about non-physical harms (harms to well-being) 23 The most contested harms to well-being 25 Conclusion: Moving the debate forward 26 References 29 ETHICAL ISSUES IN SYNTHETIC BIOLOGY: ETHICAL ISSUES IN SYNTHETIC BIOLOGY: ii The opinions expressed in this report are those of the authors and do not necessarily reflect views Sloan Foundation. Wilson International Center for Scholars or the Alfred P. of the Woodrow Ethical Issues in SYNTHETIC BIOLOGY An overview of the debates Erik Parens, Josephine Johnston, and Jacob Moses The Hastings Center, Garrison, New York SYNBIO 3 / JUNE 2009 2 ETHICAL ISSUES IN SYNTHETIC BIOLOGY: AN OVERVIEW OF THE DEBATES Preface Synthetic biology will allow scientists and where such topics are divided into two broad engineers to create biological systems categories: concerns about physical and non- that do not occur naturally as well as to physical harms. While physical harms often re-engineer existing biological systems to trigger debates about how to proceed among perform novel and beneficial tasks. This researchers, policymakers, and the public, emerging field presents a number of non-physical harms present more difficult opportunities to address ethical issues early conundrums. -
Download Monograph [PDF]
NANOTECHNOLOGY...| 1 IDSA Monograph Series No. 48 October 2015 NANOTECHNOLOGY THE EMERGING FIELD FOR FUTURE MILITARY APPLICATIONS Sanjiv Tomar 2 | SANJIV TOMAR Cover Illustration Courtesy: http://2.bp.blogspot.com/-XfhWNz2_bpY/ T3dVp2eYz1I/AAAAAAAARDY/Y3TZBL4XaHU/s1600/ 1325267213444.png available at http://fortressaustralia.blogspot.in/ 2012_04_01_archive.html Institute for Defence Studies and Analyses, New Delhi. All rights reserved. No part of this publication may be reproduced, sorted in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photo-copying, recording or otherwise, without the prior permission of the Institute for Defence Studies and Analyses (IDSA). ISBN: 978-93-82169-58-1 Disclaimer: It is certified that views expressed and suggestions made in this monograph have been made by the author in his personal capacity and do not have any official endorsement. First Published: October 2015 Price: Rs. 200/- Published by: Institute for Defence Studies and Analyses No.1, Development Enclave, Rao Tula Ram Marg, Delhi Cantt., New Delhi - 110 010 Tel. (91-11) 2671-7983 Fax.(91-11) 2615 4191 E-mail: [email protected] Website: http://www.idsa.in Cover & Layout by: Geeta Kumari Printed at: M/S A. M. Offsetters A-57, Sector-10, Noida-201 301 (U.P.) Mob: 09810888667 E-mail: [email protected] NANOTECHNOLOGY...| 3 Contents Acknowledgements 5 Abbreviations 6 Introduction 9 1. ADVENT OF NANOTECHNOLOGY 13 1.1. A Brief Historical Account 13 1.2 What makes nanoparticle properties so alluring? 16 1.3 Nanomaterials 19 2. NANOTECHNOLOGY R&D INITIATIVES AND THE CURRENT GLOBAL LANDSCAPE 23 2.1 United States 24 2.2 China 25 2.3 Russia 27 2.4 Japan 28 2.5 European Union 29 2.6 India 30 2.7 Pakistan 33 2.8 South Korea 33 2.9 Elsewhere in the World 24 3. -
Engineering Biology
WHITE PAPER ENGINEERING BIOLOGY: A PLATFORM TECHNOLOGY TO FUEL MULTI-SECTOR ECONOMIC RECOVERY AND MODERNIZE BIOMANUFACTURING IN CANADA National Engineering Biology Steering Committee November 2020 National Engineering Biology Steering Committee • Dr. Bettina Hamelin, President and CEO, Ontario Genomics (Chair) • Andrew Casey, President and CEO, BIOTECanada • Dr. Doane Chilcoat, Leader, Applied Science and Technology at Corteva Agriscience • Dr. Lakshmi Krishnan, Acting VP, Life Sciences, National Research Council • Dr. Krishna Mahadevan, Professor, University of Toronto • Dr. Vincent Martin, Director, Centre for Applied Synthetic Biology, Concordia University • Dr. Keith Pardee, Canada Research Chair in Synthetic Biology in Human Health, University of Toronto • Dr. Steve Webb, Executive Director and Chief Executive Officer, Global Institute for Food Security • Dr. Peter Zandstra, Director, Michael Smith Laboratories, University of British Columbia Observers • Pari Johnston, Vice-President, Policy and Public Affairs, Genome Canada • Dr. Yale Michaels, Banting Postdoctoral Fellow and Michael Smith Foundation for Health Research Trainee • Amy Yeung, CSBERG Director of Leadership Development, cGEM Co-Founder and Co-Director Supported by: Engineering Biology: A Platform Technology to Fuel Multi-Sector Economic Recovery and Modernize Biomanufacturing in Canada 2 Executive Summary Engineering biology tools and technologies are disrupting global markets and creating incredible opportunities for the most innovative organizations. Leading G20 jurisdictions -
November 2016 By: Dr Michael James, HREC Chair
Australasian Association of Bioethics and Health Law Melbourne - November 2016 By: Dr Michael James, HREC Chair The following expanded accounts are only those presentations for which I had taken enough notes. I attended many other presentations. Only the plenary sessions had invited presentations. The other presentations were from abstract submissions from investigators, including students, who were mainly from universities. 1. Joanna Manning , Faculty Of Law University Of Auckland Does the law on compensation for research-related injury in the UK, Australia, and New Zealand meet ethical requirements? Payment for Research Related Injury (RRI) Reliance on ex gratia payment. Is this relying on the argument that the injured person accepted a position of risk and therefore payment should not be automatic. In the UK injured participant must prove negligence or rely on ex gratia payment up to £50,000. It is preferable to have a mandated / legislated No Fault compensation and not have to rely on tort action to prove fault because unforseen risks are often the problem, Medicines Australia Guidelines state “...that the following Guidelines will be adhered to, without legal commitment,... ie without legal commitment it is an ex gratia payment. Reform would be a legislated no fault payment for RRI. It was argued that is appropriate because: The aim of the trial is to benefit society Society (regulators) mandates the need for trials for licensing purposes The injured person has accepted a position of risk but in this framework of the societal benefit of clinical trials. ---------------------------------------------------------------------------------------------------------------- 2. Angela Ballantyne, University of Otago, Wellington, New Zealand Fair research and free riders: Do patients have an ethical obligation to provide health Medical knowledge is a public good. -
Brain-Computer Interfaces: U.S. Military Applications and Implications, an Initial Assessment
BRAIN- COMPUTER INTERFACES U.S. MILITARY APPLICATIONS AND IMPLICATIONS AN INITIAL ASSESSMENT ANIKA BINNENDIJK TIMOTHY MARLER ELIZABETH M. BARTELS Cover design: Peter Soriano Cover image: Adobe Stock/Prostock-studio Limited Print and Electronic Distribution Rights This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited. Permission is given to duplicate this document for personal use only, as long as it is unaltered and complete. Permission is required from RAND to reproduce, or reuse in another form, any of our research documents for commercial use. For information on reprint and linking permissions, please visit www.rand.org/pubs/permissions.html. RAND’s publications do not necessarily reflect the opinions of its research clients and sponsors. R® is a registered trademark. For more information on this publication, visit www.rand.org/t/RR2996. Library of Congress Cataloging-in-Publication Data is available for this publication. ISBN: 978-1-9774-0523-4 © Copyright 2020 RAND Corporation Summary points of failure, adversary access to new informa- tion, and new areas of exposure to harm or avenues Brain-computer interface (BCI) represents an emerg- of influence of service members. It also underscores ing and potentially disruptive area of technology institutional vulnerabilities that may arise, includ- that, to date, has received minimal public discussion ing challenges surrounding a deficit of trust in BCI in the defense and national security policy commu- technologies, as well as the potential erosion of unit nities. This research considered key areas in which cohesion, unit leadership, and other critical inter- future BCI technologies might be relevant for the personal military relationships. -
Alex John London, Ph.D. Clara L
Alex John London, Ph.D. Clara L. West Professor of Ethics and Philosophy Carnegie Mellon University Curriculum Vitae Department of Philosophy & 1/21/21 Work: 412-268-4938 Center for Ethics and Policy Fax: 412-268-1440 Carnegie Mellon University [email protected] Pittsburgh, PA 15213-3890 https://orcid.org/0000-0002-6450-0309 https://scholar.google.com/citations?user=x-pMK90AAAAJ&hl=en https://www.scopus.com/authid/detail.uri?authorId=7005248959 EDUCATION Ph.D. Philosophy, The University of Virginia, May 1999. Dissertation: Virtue, Wisdom, and the Art of Ruling in Plato. M.A. Philosophy, The University of Virginia, May 1996. B.A. Philosophy and Literature, Bard College, May 1994. AREAS OF SPECIALIZATION AREAS OF COMPETENCE Bioethics, Ethical Theory, Ancient Philosophy, Conflict Resolution AI Ethics, Political Philosophy Wittgenstein, Criminal Justice Ethics FACULTY APPOINTMENTS 2017—Clara L. West Professor of Ethics and Philosophy, Carnegie Mellon University 2015-2020 Director, Ethics History and Public Policy Major. 2012— Professor of Philosophy, Carnegie Mellon University. 2007— Director, Center for Ethics and Policy, Carnegie Mellon University. 2005-2012 Associate Professor of Philosophy, Carnegie Mellon University. 2001— Affiliate Faculty Member, University of Pittsburgh, Center for Bioethics and Health Law. 2000-2005: Assistant Professor of Philosophy, Carnegie Mellon University. 1999-2000: Post-Doctoral Fellow, Center for Bioethics, University of Minnesota 1999: Instructor in Philosophy, The University of Virginia. HONORS AND AWARDS John & Marsha Ryan Bioethicist-in-Residence, Southern Illinois University School of Law, March 20-22, 2019. Bruce E. Siegel Memorial Lecture, Mount Carmel Health System, Columbus Ohio, Nov. 14, 2018 Elliot Dunlap Smith Award for Distinguished Teaching and Educational Service, 2016 (college wide award for excellence in teaching). -
The ELSI Advisory Board GP-Write/ the Center of Excellence For
! The ELSI Advisory Board GP-write/ The Center of Excellence for Engineering Biology Background Information on GP-write, with ELSI dimensions The Genome Project-write (GP-write) is an open, international research project led by a multi- disciplinary group of scientific leaders who will oversee a reduction in the costs of engineering and testing large genomes, including a human genome, in cell lines by over 1,000-fold within ten years. The overarching goal of such an effort is to further our understanding of the blueprint for life provided by the Human Genome Project (HGP-read) by developing new technologies and an ethical framework for genome-scale engineering, as well as transformative medical applications. GP-write will include whole genome engineering of human cell lines and other organisms of significance to research and development, agriculture, and public health, as well as organoids derived from human cells. A coordinated scientific effort to understand, discuss, and apply large genome editing technologies is timely, and public discourse regarding such an endeavor is both expected and encouraged as GP-write gets underway. However, responsible innovation requires having more than ELSI discussions; it also involves identifying common goals important to scientists and the public through timely and detailed consultation among diverse stakeholders. The GP-write effort is aimed at technology development and knowledge creation, with the ultimate goal of improving life on Earth. Potential innovations relate to biomedical therapies, food supply management, biofuels, and public health. However, as with many other technology development initiatives, there is potential for misuse, and some risks may be unforeseen. -
Rail Transit Capacity
7UDQVLW&DSDFLW\DQG4XDOLW\RI6HUYLFH0DQXDO PART 3 RAIL TRANSIT CAPACITY CONTENTS 1. RAIL CAPACITY BASICS ..................................................................................... 3-1 Introduction................................................................................................................. 3-1 Grouping ..................................................................................................................... 3-1 The Basics................................................................................................................... 3-2 Design versus Achievable Capacity ............................................................................ 3-3 Service Headway..................................................................................................... 3-4 Line Capacity .......................................................................................................... 3-5 Train Control Throughput....................................................................................... 3-5 Commuter Rail Throughput .................................................................................... 3-6 Station Dwells ......................................................................................................... 3-6 Train/Car Capacity...................................................................................................... 3-7 Introduction............................................................................................................. 3-7 Car Capacity........................................................................................................... -
Efficient Driving of CBTC ATO Operated Trains
DOCTORAL THESIS MADRID, SPAIN 2017 Efficient driving of CBTC ATO operated trains William Carvajal Carreño ESCUELA TÉCNICA SUPERIOR DE INGENIERÍA Efficient driving of CBTC ATO operated trains William Carvajal Carreño Doctoral Thesis supervisors: Senior Assoc.prof. Asunción Paloma Cucala García Universidad Pontificia Comillas Senior Assoc.prof. Antonio Fernández-Cardador Universidad Pontificia Comillas Members of the Examination Committee: Prof. Masafumi Miyatake Sophia University, Chairman Prof. Aurelio García Cerrada Universidad Pontificia Comillas, Examiner Prof. Stefan Östlund Kungliga Tekniska Högskolan, Examiner Assoc.prof. Rob Goverde Technische Universiteit Delft, Examiner Prof. Emilio Olías Ruíz Universidad Carlos III de Madrid, Examiner Senior Assoc.prof. Rafael Palacios Hielscher Universidad Pontificia Comillas, Opponent TRITA-EE 2016:201 ISSN 1653-5146 ISBN 978-84-617-7523-1 Copyright © William Carvajal-Carreño, 2017 Printed by US-AB This doctoral research was funded by the European Commission through the Erasmus Mundus Joint Doctorate Program and also partially supported by the Institute for Research in Technology at Universidad Pontificia Comillas. Efficient driving of CBTC ATO operated trains PROEFSCHRIFT ter verkrijging van de graad van doctor aan de Technische Universiteit Delft, op gezag van de Rector Magnificus prof. ir. K.C.A.M. Luyben, voorzitter van het College voor Promoties, in het openbaar te verdedigen op dinsdag 7 Maart 2017 om 12:00 uur door William CARVAJAL-CARREÑO Master in Electrical Engineering Universidad Industrial de Santander, Colombia geboren te Bucaramanga, Colombia This dissertation has been approved by the promotors: Prof. dr. ir. M.P.C. Weijnen and Senior Assoc.prof. A. P. Cucala García Composition of the doctoral committee: Prof. M. Miyatake Sophia University, Japan, Chairman Prof.